Fragrance Notes
CA Perfume
Gran Ballo
Inspired by Xerjoff · Format: EDP Spray
Safe for everyday use. This product is suitable for most adults in normal fragrance application.
Why This Score
Scores are calculated by HumanSafe™ — an independent third-party platform — using peer-reviewed toxicology sources, regulatory databases, and HumanSafe's Mood Architecture™.
Safety at a Glance
✅ Safe for
- —Daily topical use
- —Most healthy adults
- —Long-term skin contact
- —EDP leave-on format
⚠ Use with care if
- —Sensitive or reactive skin
- —Direct eye-area contact
✕ Avoid if
- —Broken or compromised skin
- —Children under 3 years
Full breakdown available to members. Join free →
Key Factors
Score DriversIngredients
30 Total| CAS No. | INCI Name | FUNCTION | ISS | Status |
|---|---|---|---|---|
| 64-17-5 | Ethanol | Solvent / Carrier | 7.0Poor | Moderate |
| 7732-18-5 | Aqua | Solvent / Carrier | 10.0 | Low Risk |
| 1222-05-5 | Ambroxan | Fragrance ingredient | 7.0A- | Moderate |
| 54464-57-2 | Tetramethyl Acetyloctahydronaphthalenes | Fragrance ingredient | 7.0B | Moderate |
| 65405-77-8 | Hexenyl Salicylate | Fragrance ingredient | 5.6Moderate | High Concern |
25 more ingredients in this formulation
See Full Ingredient List — Join Free →Ingredients sourced from MG Safety Data Sheet and EU Allergen Certificate. Formulation: fragrance oil 20% + Ethanol 65% + Aqua 15%. ⚑ = EU regulated allergen (Regulation EC 1223/2009). Note 1 = Annex II prohibited substance. Note 2 = commercial quality (includes both isomers).
Fragrance Mood Profile
MEI™ Mood ArchitectureIndex™
MEI™ scores are calculated by HumanSafe™ using HumanSafe's Mood Architecture™ — a 9-dimension olfactory-emotion mapping system. MEI is an intensity scale: 3/10 = subtle, 9/10 = immersive. Score reflects mood character, not safety.
Usage & Safety Guidance
Safer Alternatives
Higher PSS ScoreProducts with higher Product Safety Scores. Independently assessed by HumanSafe™.
Frequently Asked Questions
Is Gran Ballo safe for daily use?+
Gran Ballo's Grade B safety score suggests it is generally safe for daily application for most people. However, because it is an eau de parfum with high fragrance concentration (20.0% AMBROXAN and other potent ingredients), daily use may increase the risk of skin irritation or sensitization in individuals with reactive skin. A patch test on a small area 24–48 hours before regular use is recommended.
Are there any ingredients I should watch out for?+
The two largest unresolved compounds (totaling 32.5%) lack fully transparent chemical identification in this summary. While both have Grade A safety ratings, consumers with known fragrance sensitivities, asthma, or photosensitivity should consult the full ingredient list or a dermatologist before use. AMBROXAN, the lead ingredient, is well-established in fragrance use but may trigger reactions in highly sensitive individuals.
What does a PSS of 6.7/10 (Grade B) mean?+
The Product Safety Score (PSS) is an independent assessment of dermatological and toxicological safety based on ingredient profiles. A Grade B (6.7/10) indicates moderate safety—the product is acceptable for general use but falls short of the highest safety tier. It suggests some ingredients carry minor concerns or lack extensive long-term data, though they are not prohibited in cosmetics.
The HumanSafe™ Difference
Most safety tools rate ingredients in isolation — one score regardless of concentration, context, or how the product is used. We assess at actual use concentration.
| Dimension | Other Apps (EWG, Yuka) | HumanSafe™ |
|---|---|---|
| Dose awareness | Same score regardless of concentration | Assessed at actual use concentration in this product |
| Exposure context | Same score for rinse-off and leave-on products | Adjusted for product format and absorption rate |
| Allergens | Binary flag — present or absent | Concentration compared to IFRA/EU safe limits |
| Purchase signal | Score only, no recommendation | Clear verdict + safer alternatives ranked by PSS |
Version & Audit Trail
| Version | Date | PSS Score | ISS (avg) | Change Summary |
|---|---|---|---|---|
| v2.1.0 | April 2026 | 7.3 | — | Current assessment — PSS v4.1 route-weighted engine. Dose-aware scoring at actual use concentration. |